Key News
1. The People's Bank of China (PBOC): Promptly plan and introduce practical and effective incremental policies to strengthen counter-cyclical adjustments.
2. The PBOC announced: Overnight reverse repurchase operations will be conducted on August 14th and from August 17th to August 19th.
3. The PBOC: Reduce focus on loans as the sole financing channel, and consider loans and bond financing together.
4. The most expensive IPO this year, Pinzhun Laser: Online investors abandoned subscriptions for 10,800 shares.
5. The State-owned Assets Supervision and Administration Commission of the State Council (SASAC): Focusing on core technologies such as cloud computing, networks, artificial intelligence, and quantum computing, efforts will be intensified to tackle key core technologies.
6. By 2030, 6 trillion kilowatt-hours of green electricity will be connected to the grid, leveraging trillions of yuan in social investment.
Individual Stock News
1. Zhongding Shares: Signed a strategic cooperation agreement with Tencent Cloud, but no substantial cooperation content has yet been implemented.
2. Zijin Mining: Announced a cash dividend of RMB 0.42 per share for the first half of 2026, with the record date being August 20th.
3. Liyuan Information: Murata inductor products began raising prices in July.
4. Zhongkuang Resources' 100,000-ton-per-year lithium sulfate project in Zimbabwe has fully commenced construction.
5. Zhaori Technology: Plans to acquire control of Bainai Technology; stock resumes trading.
6. ShuoBeide: Plans to raise no more than 1.096 billion yuan through private placement for server cooling module projects, etc.
7. Chuanzhi Education (9 out of 13 days of limit-up trading): The company's stock has recently been under close monitoring by the Shenzhen Stock Exchange; further abnormal price increases may trigger a trading halt for investigation.
8. Tianfu Communication: Plans to implement a restricted stock incentive plan of 2.2887 million shares, with performance targets of net profit growth rates of no less than 120%, 320%, and 560% respectively from 2025 to 2027-2029.
9. Baihua Pharmaceutical (7 consecutive limit-up days): Not involved in innovative drug development; the controlling shareholder has no plans or arrangements for major asset restructuring within the next 36 months.
